3 June 2024 - trading opportunity
We suggested that readers should sell GSK at 1810p on 15 May following the strong run in the share price. The shares have now dropped to 1599p,following negative news on Zantac this morning and this provides the perfect opportunity to close short positions. Buying back at 1599p has generated a profit of 211p or 11.6% in under three weeks. This is an excellent result for traders. BUY.
. . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
